Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18975086 | INTRAVASCULAR IMAGING CATHETER | December 2024 | February 2026 | Allow | 15 | 1 | 0 | No | No |
| 18974220 | BIMODAL METHOD FOR DETECTION AND MEASUREMENT OF MACULAR PIGMENTS IN RETINA TISSUE | December 2024 | November 2025 | Allow | 11 | 2 | 0 | No | No |
| 18962176 | MAGNETIC TOLERANT IMAGING | November 2024 | March 2026 | Allow | 15 | 1 | 0 | No | No |
| 18923852 | MRI Compatible Interventional Wireguide | October 2024 | March 2026 | Allow | 17 | 1 | 0 | No | No |
| 18882672 | Signal Processing Methods and Systems for Biomagnetic Field Imaging | September 2024 | February 2026 | Allow | 17 | 1 | 0 | No | No |
| 18812581 | NEUROMODULATION TECHNIQUES | August 2024 | February 2026 | Allow | 18 | 1 | 0 | No | No |
| 18809058 | SYSTEMS, DEVICES, AND METHODS OF TREATING TISSUE AND CELLULITE BY NON-INVASIVE ACOUSTIC SUBCISION | August 2024 | March 2026 | Abandon | 18 | 1 | 0 | No | No |
| 18796498 | MEDICAL SYSTEMS AND RELATED METHODS | August 2024 | January 2026 | Allow | 17 | 1 | 0 | No | No |
| 18777481 | HYBRID ELECTROMAGNETIC DEVICE FOR REMOTE CONTROL OF MICRO-NANO SCALE ROBOTS, MEDICAL TOOLS AND IMPLANTABLE DEVICES | July 2024 | March 2026 | Abandon | 20 | 1 | 0 | No | No |
| 18762863 | SENSORS FOR CATHETER PUMPS | July 2024 | February 2026 | Allow | 20 | 1 | 0 | No | No |
| 18726442 | MEDICAL IMAGE ACQUISITION UNIT ASSISTANCE APPARATUS | July 2024 | January 2026 | Allow | 19 | 1 | 0 | No | No |
| 18752394 | BIOMETRIC APPARATUS, BIOMETRIC METHOD, AND NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM | June 2024 | January 2026 | Abandon | 19 | 3 | 0 | Yes | No |
| 18660170 | SYSTEM AND METHOD FOR LOCAL THREE DIMENSIONAL VOLUME RECONSTRUCTION USING A STANDARD FLUOROSCOPE | May 2024 | February 2026 | Allow | 21 | 3 | 0 | No | No |
| 18658540 | IMAGE PROCESSING APPARATUS, MEDICAL IMAGE DIAGNOSTIC APPARATUS, AND BLOOD PRESSURE MONITOR | May 2024 | November 2025 | Allow | 18 | 2 | 0 | No | No |
| 18608794 | HYBRID REGISTRATION METHOD | March 2024 | October 2025 | Allow | 19 | 1 | 0 | No | No |
| 18603191 | Artificial Intelligence System for Comprehensive Medical Diagnosis, Prognosis, and Treatment Optimization through Medical Imaging | March 2024 | March 2026 | Allow | 24 | 1 | 0 | No | No |
| 18400832 | INTRAOPERATIVE VIDEO REVIEW | December 2023 | October 2025 | Allow | 21 | 3 | 0 | No | No |
| 18524898 | SYSTEM AND METHOD FOR NAVIGATION | November 2023 | December 2025 | Allow | 25 | 2 | 0 | No | No |
| 18512580 | MAP DEFORMATION FOR ANATOMICAL MAPPING | November 2023 | October 2025 | Allow | 23 | 1 | 0 | No | No |
| 18278167 | Self-Learning and Non-Invasive Bladder Monitoring Systems and Methods | August 2023 | October 2025 | Allow | 26 | 1 | 0 | No | No |
| 18276989 | CALIBRATION CRADLE FOR THREE-DIMENSIONAL SCANNER | August 2023 | February 2026 | Allow | 30 | 1 | 0 | No | No |
| 18274478 | MRI SYSTEM, IN PARTICULAR A METHOD AND SYSTEM FOR GENERATING A CARDIAC TRIGGER SIGNAL | July 2023 | June 2025 | Allow | 23 | 1 | 0 | No | No |
| 18336807 | METHOD AND APPARATUS FOR PERFORMING SINGLE GATING IN POSITRON EMISSION TOMOGRAPY SYTEMS | June 2023 | February 2026 | Allow | 32 | 1 | 0 | No | No |
| 18114320 | Technique for Determining a Marker Arrangement That Defines Marker Positions of a Tracker | February 2023 | October 2025 | Allow | 32 | 1 | 0 | No | No |
| 17927054 | METHOD AND APPARATUS FOR MULTIMODAL SOFT TISSUE DIAGNOSTICS | November 2022 | December 2025 | Allow | 36 | 1 | 1 | No | No |
| 17957345 | TECHNIQUES FOR HEART RATE DETECTION | September 2022 | February 2026 | Allow | 40 | 3 | 0 | Yes | No |
| 17904679 | PREDICTING SUCCESSFUL GENERATION AND INHIBITION OF SEIZURE-LIKE AFTERDISCHARGES AND MAPPING THEIR SEIZURE NETWORKS USING FMRI | August 2022 | October 2025 | Allow | 38 | 1 | 0 | No | No |
| 17746041 | WIRELESS GATING SYSTEM FOR MAGNETIC RESONANCE IMAGING | May 2022 | December 2025 | Allow | 43 | 1 | 1 | No | No |
| 17711023 | DEVICE AND METHOD FOR ASSISTING LAPAROSCOPIC SURGERY - DIRECTING AND MANEUVERING ARTICULATING TOOL | March 2022 | March 2026 | Abandon | 47 | 4 | 0 | No | No |
| 17503253 | DETERMINATION OF WHITE-MATTER NEURODEGENERATIVE DISEASE BIOMARKERS | October 2021 | November 2025 | Allow | 49 | 1 | 0 | No | No |
| 17368756 | AUTOMATIC TRACKING OF TARGET TREATMENT SITES WITHIN PATIENT ANATOMY | July 2021 | November 2025 | Allow | 52 | 4 | 0 | No | No |
| 16050318 | FORMULATION OF SOLID NANO-SIZED PARTICLES IN A GEL-FORMING SYSTEM | July 2018 | June 2019 | Allow | 10 | 2 | 0 | No | No |
| 15295389 | AUTOMATIC EXTRACTION OF DISEASE-SPECIFIC FEATURES FROM DOPPLER IMAGES | October 2016 | February 2019 | Allow | 28 | 1 | 0 | No | No |
| 15158503 | MEDICAL DEVICE GUIDEWIRE WITH HELICAL CUTOUT AND COATING | May 2016 | December 2018 | Allow | 31 | 4 | 0 | No | Yes |
| 14481414 | ULTRASONIC DIAGNOSTIC APPARATUS, IMAGE PROCESSING APPARATUS, AND IMAGE PROCESSING METHOD | September 2014 | September 2018 | Allow | 48 | 3 | 0 | No | No |
| 14301540 | PORTABLE ULTRASONIC PROBE HAVING A FOLDER PART | June 2014 | February 2019 | Allow | 56 | 3 | 0 | No | No |
| 11915625 | VELOCITY MEASURING METHOD AND VELOCITY MEASURING DEVICE USING THE SAME | March 2009 | January 2011 | Allow | 37 | 2 | 0 | Yes | No |
| 12114888 | T1-CORRECTED PROTON RESONANCE FREQUENCY SHIFT THERMOMETRY | May 2008 | June 2011 | Allow | 38 | 1 | 0 | No | No |
| 11970707 | APPARATUS AND METHOD FOR ALIGNING A LIGHT POINTER WITH A MEDICAL INTERVENTIONAL DEVICE TRAJECTORY | January 2008 | May 2012 | Allow | 52 | 3 | 0 | No | Yes |
| 11904413 | MEDICAL SYSTEM COMPRISING A DETECTION DEVICE FOR DETECTING AN OBJECT AND COMPRISING A STORAGE DEVICE AND METHOD THEREOF | September 2007 | July 2012 | Allow | 57 | 5 | 0 | No | No |
| 11179044 | METHOD AND APPARATUS FOR SURGICAL NAVIGATION | July 2005 | March 2012 | Allow | 60 | 6 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BRUTUS, JOEL F.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner BRUTUS, JOEL F works in Art Unit 3797 and has examined 12 patent applications in our dataset. With an allowance rate of 100.0%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 49 months.
Examiner BRUTUS, JOEL F's allowance rate of 100.0% places them in the 100% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.
On average, applications examined by BRUTUS, JOEL F receive 2.92 office actions before reaching final disposition. This places the examiner in the 85% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by BRUTUS, JOEL F is 49 months. This places the examiner in the 7% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +0.0% benefit to allowance rate for applications examined by BRUTUS, JOEL F. This interview benefit is in the 17% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.
When applicants file an RCE with this examiner, 28.6% of applications are subsequently allowed. This success rate is in the 52% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 44.4% of cases where such amendments are filed. This entry rate is in the 68% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 100% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 100% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 8.3% of allowed cases (in the 91% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.